Loading company…
mCurex Therapeutics develops mRNA vaccines and therapeutics.
mCurex Therapeutics researches and develops mRNA vaccines and therapeutics, including candidates for COVID-19 and potential applications in influenza, cancer, respiratory and liver diseases. Established in 2021 and based in Seongnam, South Korea, the company is a subsidiary of OliX Pharmaceuticals. It partnered with ToolGen and Samyang Holdings on mRNA gene therapy research.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in